Audit 394931

FY End
2025-06-30
Total Expended
$52.89M
Findings
79
Programs
31
Organization: National Jewish Health (CO)
Year: 2025 Accepted: 2026-03-26

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1187327 2025-001 Material Weakness Yes F
1187328 2025-001 Material Weakness Yes F
1187329 2025-001 Material Weakness Yes F
1187330 2025-001 Material Weakness Yes F
1187331 2025-001 Material Weakness Yes F
1187332 2025-001 Material Weakness Yes F
1187333 2025-001 Material Weakness Yes F
1187334 2025-001 Material Weakness Yes F
1187335 2025-001 Material Weakness Yes F
1187336 2025-001 Material Weakness Yes F
1187337 2025-001 Material Weakness Yes F
1187338 2025-001 Material Weakness Yes F
1187339 2025-001 Material Weakness Yes F
1187340 2025-001 Material Weakness Yes F
1187341 2025-001 Material Weakness Yes F
1187342 2025-001 Material Weakness Yes F
1187343 2025-001 Material Weakness Yes F
1187344 2025-001 Material Weakness Yes F
1187345 2025-001 Material Weakness Yes F
1187346 2025-001 Material Weakness Yes F
1187347 2025-001 Material Weakness Yes F
1187348 2025-001 Material Weakness Yes F
1187349 2025-001 Material Weakness Yes F
1187350 2025-001 Material Weakness Yes F
1187351 2025-001 Material Weakness Yes F
1187352 2025-001 Material Weakness Yes F
1187353 2025-001 Material Weakness Yes F
1187354 2025-001 Material Weakness Yes F
1187355 2025-001 Material Weakness Yes F
1187356 2025-001 Material Weakness Yes F
1187357 2025-001 Material Weakness Yes F
1187358 2025-001 Material Weakness Yes F
1187359 2025-001 Material Weakness Yes F
1187360 2025-001 Material Weakness Yes F
1187361 2025-001 Material Weakness Yes F
1187362 2025-001 Material Weakness Yes F
1187363 2025-001 Material Weakness Yes F
1187364 2025-001 Material Weakness Yes F
1187365 2025-001 Material Weakness Yes F
1187366 2025-001 Material Weakness Yes F
1187367 2025-001 Material Weakness Yes F
1187368 2025-001 Material Weakness Yes F
1187369 2025-001 Material Weakness Yes F
1187370 2025-001 Material Weakness Yes F
1187371 2025-001 Material Weakness Yes F
1187372 2025-001 Material Weakness Yes F
1187373 2025-001 Material Weakness Yes F
1187374 2025-001 Material Weakness Yes F
1187375 2025-001 Material Weakness Yes F
1187376 2025-001 Material Weakness Yes F
1187377 2025-001 Material Weakness Yes F
1187378 2025-001 Material Weakness Yes F
1187379 2025-001 Material Weakness Yes F
1187380 2025-001 Material Weakness Yes F
1187381 2025-001 Material Weakness Yes F
1187382 2025-001 Material Weakness Yes F
1187383 2025-001 Material Weakness Yes F
1187384 2025-001 Material Weakness Yes F
1187385 2025-001 Material Weakness Yes F
1187386 2025-001 Material Weakness Yes F
1187387 2025-001 Material Weakness Yes F
1187388 2025-001 Material Weakness Yes F
1187389 2025-001 Material Weakness Yes F
1187390 2025-001 Material Weakness Yes F
1187391 2025-001 Material Weakness Yes F
1187392 2025-001 Material Weakness Yes F
1187393 2025-001 Material Weakness Yes F
1187394 2025-001 Material Weakness Yes F
1187395 2025-001 Material Weakness Yes F
1187396 2025-001 Material Weakness Yes F
1187397 2025-001 Material Weakness Yes F
1187398 2025-001 Material Weakness Yes F
1187399 2025-001 Material Weakness Yes F
1187400 2025-001 Material Weakness Yes F
1187401 2025-001 Material Weakness Yes F
1187402 2025-001 Material Weakness Yes F
1187403 2025-001 Material Weakness Yes F
1187404 2025-001 Material Weakness Yes F
1187405 2025-001 Material Weakness Yes F

Programs

ALN Program Spent Major Findings
93.U02 National Institute of Health Contract $9.44M Yes 1
93.350 NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES $644,527 Yes 1
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $621,995 Yes 1
93.846 ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH $503,764 Yes 1
93.387 NATIONAL AND STATE TOBACCO CONTROL PROGRAM $375,311 Yes 0
93.U01 COVID-19 National Heart, Lung and Blood Institute $374,090 Yes 1
93.233 NATIONAL CENTER ON SLEEP DISORDERS RESEARCH $311,242 Yes 1
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $242,760 Yes 1
93.305 PPHF 2018: OFFICE OF SMOKING AND HEALTH-NATIONAL STATE-BASED TOBACCO CONTROL PROGRAMS-FINANCED IN PART BY 2018 PREVENTION AND PUBLIC HEALTH FUNDS (PPHF) $217,000 Yes 0
93.493 CONGRESSIONAL DIRECTIVES $214,680 Yes 1
93.839 BLOOD DISEASES AND RESOURCES RESEARCH $201,701 Yes 1
93.257 GRANTS FOR EDUCATION, PREVENTION, AND EARLY DETECTION OF RADIOGENIC CANCERS AND DISEASES $125,804 Yes 1
93.840 TRANSLATION AND IMPLEMENTATION SCIENCE RESEARCH FOR HEART, LUNG, BLOOD DISEASES, AND SLEEP DISORDERS $109,334 Yes 1
93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH $106,611 Yes 1
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $86,992 Yes 1
93.113 COVID-19 ENVIRONMENTAL HEALTH $82,686 Yes 1
93.U03 National Institute of Health Contract $77,827 Yes 1
93.866 AGING RESEARCH $55,829 Yes 1
93.838 LUNG DISEASES RESEARCH $44,193 Yes 1
93.837 CARDIOVASCULAR DISEASES RESEARCH $44,061 Yes 1
81.108 EPIDEMIOLOGY AND OTHER HEALTH STUDIES FINANCIAL ASSISTANCE PROGRAM $41,903 Yes 1
93.226 RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES $32,633 Yes 1
93.361 NURSING RESEARCH $26,247 Yes 1
93.113 ENVIRONMENTAL HEALTH $12,178 Yes 1
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $11,247 Yes 1
93.965 COAL MINERS RESPIRATORY IMPAIRMENT TREATMENT CLINICS AND SERVICES $11,146 Yes 0
10.310 AGRICULTURE AND FOOD RESEARCH INITIATIVE (AFRI) $9,746 Yes 1
93.855 COVID-19 ALLERGY AND INFECTIOUS DISEASES RESEARCH $9,743 Yes 1
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $6,621 Yes 1
27.011 INTERGOVERNMENTAL PERSONNEL ACT (IPA) MOBILITY PROGRAM $6,130 Yes 1
93.394 CANCER DETECTION AND DIAGNOSIS RESEARCH $368 Yes 1

Contacts

Name Title Type
VLQKFEEJ3NE9 Michael Dickman Auditee
3033981866 Anna Thigpen Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal award activity of National Jewish Health and Subsidiary (National Jewish Health) under programs of the federal government for the year ended June 30, 2025. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of National Jewish Health, it is not intended to and does not present the financial position, changes in net assets or cash flows of National Jewish Health.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
National Jewish Health has elected not to use the de minimis indirect cost rate allowed under the Uniform Guidance and instead to use its federally approved indirect cost rate.

Finding Details

2025-001 Finding: Equipment Federal Program: Research and Development Cluster, Various Assistance Listing Numbers, Various Agencies, Award Year 2025 Criteria or Specific Requirement: Uniform Guidance (2 CFR 200.313(d)) requires non-federal entities to maintain effective control and accountability for all federally funded equipment, including procedures to ensure assets exist, are used for authorized purposes, and are properly disposed of when no longer needed. Uniform Guidance further contemplates periodic physical inventories of equipment and reconciliation to property records at least once every two years. Policies and procedures should address all federal awards, regardless of awarding agency. Condition: Out of a sample of 25 assets, five assets with acquisition dates between 1990 and 2016, had been disposed but not removed from the asset subledger. In addition, a full inventory of federally funded assets was not completed within a two year timeframe and key data was not reconciled. Our sampling methodology was not, and was not intended to be, statistically valid. Questioned Costs: $52,511.60 - Costs relate to multiple awards within the Research and Development Cluster. Cause: The Organization's fixed asset monitoring policy is primarily designed to comply with National Institute of Health requirements and has not been expanded to fully incorporate Uniform Guidance requirements applicable to all federal awards. Controls were not operating as designed to identify and remove assets from the subledger when disposed. Effect: As a result, the Organization’s fixed asset records were not fully accurate or complete for certain federally funded assets, increasing the risk that assets disposed of in prior years remain recorded in the subledger and that federally funded equipment is not consistently tracked in accordance with Uniform Guidance. Identification as a repeat finding: Not a repeat finding Recommendation: We recommend that the Organization expands and formalizes its fixed asset monitoring policy to fully align with Uniform Guidance requirements, including (1) Performing and documenting a physical inventory of federally funded equipment at least once every two years, with reconciliation to the fixed asset subledger. (2) Ensuring timely communication and documentation of asset disposals to Finance for record updates. Views of Responsible Officials: The Organization agrees with the finding. See separate auditee document for planned corrective action.